VIR Q2 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$86,000-96.3% YoY

Gross Profit

-$30M-34557.0% margin

Operating Income

-$36M-41591.9% margin

Net Income

-$34M-39451.2% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+405.9%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$27M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$457M

Total Liabilities

$55M

Stockholders' Equity

$401M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86,000	$2M	-96.3%
Gross Profit	-$30M	-$21M	-42.4%
Operating Income	-$36M	-$28M	-28.9%
Net Income	-$34M	-$28M	-21.1%